4//SEC Filing
Echo Therapeutics, Inc. 4
Accession 0001140361-14-027289
CIK 0001031927operating
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 6:24 PM ET
Size
19.3 KB
Accession
0001140361-14-027289
Insider Transaction Report
Form 4
LANDESMAN URI
10% Owner
Transactions
- Purchase
Common Stock
2014-06-27$2.20/sh+10,656$23,443→ 623,369 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.) - Purchase
Common Stock
2014-06-30$2.20/sh+55,083$121,183→ 678,452 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.)
Holdings
- 1,605,424(indirect: By Platinum Partners Value Arbitrage Fund L.P.)
Common Stock
Transactions
- Purchase
Common Stock
2014-06-30$2.20/sh+55,083$121,183→ 678,452 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.) - Purchase
Common Stock
2014-06-27$2.20/sh+10,656$23,443→ 623,369 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.)
Holdings
- 1,605,424(indirect: By Platinum Partners Value Arbitrage Fund L.P.)
Common Stock
Nordlicht Mark
10% Owner
Transactions
- Purchase
Common Stock
2014-06-27$2.20/sh+10,656$23,443→ 623,369 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.) - Purchase
Common Stock
2014-06-30$2.20/sh+55,083$121,183→ 678,452 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.)
Holdings
- 1,605,424(indirect: By Platinum Partners Value Arbitrage Fund L.P.)
Common Stock
Transactions
- Purchase
Common Stock
2014-06-27$2.20/sh+10,656$23,443→ 623,369 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.) - Purchase
Common Stock
2014-06-30$2.20/sh+55,083$121,183→ 678,452 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.)
Holdings
- 1,605,424(indirect: By Platinum Partners Value Arbitrage Fund L.P.)
Common Stock
Platinum Management (NY) LLC
10% Owner
Transactions
- Purchase
Common Stock
2014-06-30$2.20/sh+55,083$121,183→ 678,452 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.) - Purchase
Common Stock
2014-06-27$2.20/sh+10,656$23,443→ 623,369 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.)
Holdings
- 1,605,424(indirect: By Platinum Partners Value Arbitrage Fund L.P.)
Common Stock
Platinum-Montaur Life Sciences, LLC
10% Owner
Transactions
- Purchase
Common Stock
2014-06-30$2.20/sh+55,083$121,183→ 678,452 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.) - Purchase
Common Stock
2014-06-27$2.20/sh+10,656$23,443→ 623,369 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.)
Holdings
- 1,605,424(indirect: By Platinum Partners Value Arbitrage Fund L.P.)
Common Stock
Transactions
- Purchase
Common Stock
2014-06-30$2.20/sh+55,083$121,183→ 678,452 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.) - Purchase
Common Stock
2014-06-27$2.20/sh+10,656$23,443→ 623,369 total(indirect: By Platinum Partners Liquid Opportunity Master Fund L.P.)
Holdings
- 1,605,424(indirect: By Platinum Partners Value Arbitrage Fund L.P.)
Common Stock
Footnotes (3)
- [F1]This Form 4 is filed jointly by Platinum Partners Value Arbitrage Fund L.P. ("PPVA"), Platinum Partners Liquid Opportunity Master Fund L.P. ("PPLO"), Platinum-Montaur Life Sciences, LLC ("Platinum-Montaur"), Platinum Management (NY) LLC ("Platinum Management"), Platinum Liquid Opportunity Management (NY) LLC ("Platinum Liquid Management"), Mark Nordlicht and Uri Landesman (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.
- [F2]Securities owned directly by PPLO. Each of Platinum Liquid Management, as the Investment Manager of PPLO, and Mark Nordlicht and Uri Landesman, as the Chief Investment Officer and President, respectively, of Platinum Liquid Management, may be deemed to beneficially own the securities owned directly by PPLO.
- [F3]Securities owned directly by PPVA. Each of Platinum Management, as the Investment Manager of PPVA, and Mark Nordlicht and Uri Landesman, as the Chief Investment Officer and President, respectively, of Platinum Management, may be deemed to beneficially own the securities owned directly by PPVA.
Documents
Issuer
Echo Therapeutics, Inc.
CIK 0001031927
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001031927
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 6:24 PM ET
- Size
- 19.3 KB